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Abstract
Background: Low back pain is a common and costly health complaint for which there are several moderately
effective treatments. In some fields there is evidence that funder and financial conflicts are associated with trial
outcomes. It is not clear whether effect sizes in back pain trials relate to journal impact factor, reporting conflicts of
interest, or reporting funding.
Methods: We performed a systematic review of English-language papers reporting randomised controlled trials of
treatments for non-specific low back pain, published between 2006-2012. We modelled the relationship using 5-year
journal impact factor, and categories of reported of conflicts of interest, and categories of reported funding (reported
none and reported some, compared to not reporting these) using meta-regression, adjusting for sample size, and
publication year. We also considered whether impact factor could be predicted by the direction of outcome, or trial
sample size.
Results: We could abstract data to calculate effect size in 99 of 146 trials that met our inclusion criteria. Effect size is
not associated with impact factor, reporting of funding source, or reporting of conflicts of interest. However, explicitly
reporting ‘no trial funding’ is strongly associated with larger absolute values of effect size (adjusted β = 1.02 (95% CI
0.44 to 1.59), P = 0.001). Impact factor increases by 0.008 (0.004 to 0.012) per unit increase in trial sample size
(P < 0.001), but does not differ by reported direction of the LBP trial outcome (P = 0.270).
Conclusions: The absence of associations between effect size and impact factor, reporting sources of funding, and
conflicts of interest reflects positively on research and publisher conduct in the field. Strong evidence of a large
association between absolute magnitude of effect size and explicit reporting of ‘no funding’ suggests authors of
unfunded trials are likely to report larger effect sizes, notwithstanding direction. This could relate in part to quality,
resources, and/or how pragmatic a trial is.
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Background
Low back pain (LBP) is a common and costly health com-
plaint for which the life-time prevalence may be as high
as 84% [1]. Each year approximately 4% of the UK pop-
ulation take time off work because of LBP; this equates
to around 90 million working days lost and between
eight and 12 million GP consultations per year [2, 3].
Globally, LBP ranks number one for contributions to
Years Lived with Disability (YLDs) [4]. Several therapist-
delivered interventions have been identified as useful for
the early management of persistent non-specific LBP [5].
It can be difficult to choose which interventions will suit
which patients, so guidelines recommend taking account
of patient preference [5]. This is in part due to the dif-
ferent reporting methods used, the variance of reported
effect sizes and a paradox that in the largest trials effect
sizes tend to be quite similar irrespective of intervention
and small to medium inmagnitude [6, 7].We are currently
unable to determine for whom a particular treatment will
be effective, as outcome has not often been shown to
be dependent on participant characteristics [8]. Notwith-
standing these challenges, a great deal of trust is placed in
authors’ work and their estimates of treatment effect sizes,
which inform decision-making and policy [9].
Readers of LBP trial reports often look first at the
abstract and conclusion [9]. Some go on to look at poten-
tial known sources of bias such as lack of allocation
concealment or lack of outcome assessment blinding [9].
Fewer examine funding source or conflicts of interest,
possibly because it is generally assumed that, except in
exceptional circumstances, these are unlikely to materi-
ally affect results. However, in 2010, an additional item
recommending the reporting of trial funding was added
to the CONSORT statement following the emergence of
evidence that studies sponsored by pharmaceutical com-
panies were more likely to have outcomes favouring the
sponsor than studies with other sponsors, with an odds
ratio of 4.05, (95% CI 2.98 to 5.51) [10, 11]. While CON-
SORT does not specifically recommend reporting con-
flicts of interest, this is a requirement for submission
to most journals. Bekelman et al found, in a review of
reviews, that those with financial conflicts of interest were
more likely to report a result in favour of pro-industry
conclusions, with an odds ratio of 3.60 (95% CI 2.63 to
4.91) [12]. Given the challenges to choosing between treat-
ments for LBP, it is important to explore whether such an
association is present in the field of LBP research. This
will help to inform consumers’ interpretations of LBP trial
results in the case a similarly large association exists.
Journal impact factors (IFs) quantify the average num-
ber of citations per article published in a particular journal
over a specific time period; usually, the past two, or the
past five-years. The Thomson Reuters Institute for Sci-
entific Information (ISI), tracks both publications and
citations of articles across journals. While use of IFs have
been criticised,[13] they are widely regarded as a proxy
of output quality and journal esteem, and are commonly
used for advertising and self-promotion by journals on
the home pages of their websites [13, 14]. Consequently,
many authors select a target journal publication in-part
based on that journal’s IF [15]. Effect sizes are known
to become smaller as the quality of the study improves
and we wanted to determine if a similar phenomenon
occurred with IF, an established proxy for journal qual-
ity [16, 17]. It is not known whether the IF of a journal
is associated with reported outcomes in LBP research.
Submission and acceptance patterns could be influenced
by several factors including perceived interest factor; per-
ceived quality; how newsworthy a report is, especially
if it is particularly novel, or goes against accepted prac-
tice in showing a null or negative result for a commonly
used treatment; or how topical it is. We hypothesised
that the direction or magnitude of treatment effect size is
associated with journal IF.
We systematically reviewed trials of treatments for non-
specific LBP to explore methodological factors as part of
a larger project. In this paper, we test the null hypothe-
ses that reported effect sizes in non-specific LBP trials are
independent of (1) five-year journal IF, (2) reporting of
conflicts of interest, and (3) reporting of funding sources.
We also explored whether direction of outcome and trial
sample size is associated with IF to find the extent to
which these two factors are related to IF.
Methods
Our focus was on trials comparing any interventions for
treating non-specific LBP,measuring any patient-reported
continuous (or quasi-continuous) outcome, and published
over a five-year period. We included all reports of trials
for interventions for non-specific LBP unless theymet one
or more of the following exclusion criteria: reports that
self-identified as pilot/feasibility studies; trials including
mixed samples of back pain (e.g. including neck or tho-
racic pain in addition to LBP); LBP due to known pathol-
ogy (e.g cancer, ankylosing spondylitis, or disc herniation);
LBP associated with pregnancy; non-English language
publications; samples that included participants with radi-
ating leg pain, or referred pain extending past the knee;
and because of limited utility: non-inferiority designs (i.e.
trials of interventions that are hypothesised to be non-
different with respect to a given delta); cross-over designs;
secondary reports; trials using solely objective or psycho-
logical outcome measures; and multiple publications. In
the case of multiple publications, we included the first
published article and excluded subsequent publications.
We searched PubMed, EMBASE, and The Cochrane
Register of Controlled Trials for non-specific LBP trials
published between January 1, 2006 and January 1, 2012
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using the non-specific LBP string from a Cochrane Back
Pain Review group search strategy [18]. Two reviewers
(either TB, PB, or DR) working independently, identified
all randomised controlled trial (RCT) reports for inclusion
by combining all database hits in an Endnote (Version 14;
Thomson Reuters, Philadelphia) library, removing dupli-
cates, and short-listing by title and abstract. Full-texts
were obtained if the titles and abstract alone contained
insufficient information.
Data abstraction
Using Microsoft Visual Basic 6.3 (Microsoft, Washington)
andMicrosoft Office Excel 2003 (Microsoft,Washington),
we developed a front-end program to assist the data
abstraction process and transfer abstracted data to a
spread sheet. The program ensured consistency of data
abstraction and comprehensive form completion as it
insisted on correct completion of each field, producing
error messages alerting reviewers to missed fields.
Two reviewers (either TB, PB, DR) independently
abstracted all data. Disagreements were resolved through
discussion and, if necessary, with arbitration and a fourth
reviewer (RF). First the primary outcome was identified.
An outcome measure was identified as ‘primary’ if (1) the
outcome was nominated as the primary outcome by the
authors; if no outcome was nominated, or multiple out-
comes were nominated, we used (2) the outcome measure
on which the sample size calculation was based; if this
was not reported, we referred to (3) the first outcome
measure referred to in the abstract; and if this was not
identified in the abstract, we used (4) the first outcome
mentioned in the paper. This approach has been used in
other methodological reviews [19]. We identified the pri-
mary end-point, or used the first follow-up time point in
cases when this was not clear. We then abstracted data on
standardised effect size according to a set protocol.
First, we identified whether the paper reported a
between-group difference in the primary outcome, or
change scores or baseline and follow-up scores for each
group from which we could calculate the between-group
difference. The difference was recorded as positive if it
favoured the intervention and negative if it favoured the
control or comparison intervention. If there were more
than two groups (and therefore more than two compar-
isons) we included the comparison with the largest effect
size. To obtain the standardised effect size, if it was not
directly reported, we extracted a pooled baseline SD, if
available, otherwise we extracted SDs from baseline or
change scores from single arms and calculated a pooled
SD. We then divided the between-group difference by the
SD to obtain the standardised effect size (i.e the standard-
ised mean difference (SMD)) [20].
Second, we identified if the paper reported a stan-
dard error (SE) for the between-group difference. As the
SE relates to the standard deviation of a specific out-
come measure, and since we were looking at different
outcome measures, we needed to re-standardise the SE
across all outcomemeasures. We divided the SE by the SD
extracted or calculated in the previous step to produce a
re-standardised SE (SSEα). If SE for between-group differ-
ence was not reported, we identified whether a 95% CI
was reported for the between-group difference, and under
the assumption of normality, we calculated the standard-
ised SE according to Eq. 1 (SSEβ ).We prioritised these first
two methods respectively where they were available, as
these represent the adjusted errors in cases where authors
included covariates within modelling. If neither the SE
nor CI for a between-group difference was reported, then
we estimated the crude standardised SE for the between-
group difference (SSE). As the outcomes in these LBP
trials are patient reported and quasi-continuous in nature,
the SE is calculated as σ√n in each arm. On standardising
this by the SD the expression simplifies to that shown in
Eq. 2.
SSEβ = Upp − Lwr2 × 1.96 × σb (1)
SSE = 1√nt +
1√nc (2)
where Upp=the upper limit of the 95% CI, and Lwr=
the lower limit of the 95% CI; n=sample size, t=treatment
group, c=control/comparator group, σb=the pooled base-
line SD.
If, during any of these steps, the required information
could not be ascertained, we recorded the reason and
did not analyse data from that paper. For consistency in
this process we developed a flow chart for reviewers’ use
(Additional file 1).
In addition, we abstracted data on the number of par-
ticipants on whom data were analysed, COIs, classifying
these as either ‘not reported’, ‘none reported’, or ‘some
reported’; and funding status, which we classified in the
same way. We used 2011 five-year IF for the correspond-
ing journals, which we obtained from Thompson Reuters
ISI Web of Knowledge (Thompson Reuters, Philadelphia).
Analysis
We tested the null hypotheses that effect size is indepen-
dent of (1) 5-year journal IF; (2) COI reporting category;
and (3) funding reporting category. As high-magnitude
departures from the null value regardless of direction of
effect size might be equally attractive to some journals,
we also explored relationships to the absolute value of
effect size. We explored sample size by COI and funding
reporting category compared to not reporting any details,
whether sample size was independent of journal IF, and
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whether there was any difference in journal IF in journals
publishing positive and negative trial reports.
We fitted random effects meta-regression models of
effect size on IF, COI category, and funding status, using
within-study SSEs (vide supra) to weight observations.We
used a restricted maximum likelihood (REML) estimator
for between-study variance [21–23]. Within the REML
algorithm used, coefficients as well as between-study vari-
ance was estimated with weighted least squares, so error
terms were unbiased by heteroschedasticity [24, 25]. In
the case that a journal did not have an official IF, we
imputed an IF value of zero. We performed sensitivity
analyses, using log-transformed IF (involving small non-
zero imputations for journals with no official impact fac-
tor) and sample size, to allay concerns that readers more
familiar with transformations than REML estimation to
overcome heteroschedasticity might have in relation to
the heteroschedasticity.
We first fitted crude models, i.e. with only the outcome
and predictor variable for each hypothesis, and subse-
quently fitted adjusted models including the other predic-
tor variables; i.e IF, COI category, and funding category,
as well as trial sample size, and publication year, in case
relationships changed over time. If predictors appeared
non-linear we explored fitting polynomial terms to the
model.
Model fits were assessed by graphical examination of
standardised predicted random effects. We did not dis-
miss models on the basis of a high proportion of residual
error explained by heterogeneity (i.e. I2), since our focus
was on the associations between effect size and character-
istics across a number of different interventions and not
on estimation of any one intervention effect in particular.
All analyses were performed using Stata, version 12.1 for
Unix (Statacorp, Texas) and we used the package metareg
v2.6.1 to fit the meta-regression models [24, 26].
Results
Figure 1 details hits obtained from the databases searched,
exclusions made at the title and abstract phase, and 165
rejections at full-text level [27–191].
We could abstract the required effect size data on 99 tri-
als [192–290] from the 146 articles that met inclusion cri-
teria [192–337]. We could not abstract data on SD for the
remaining 47 cases (Additional file 1). (Additional file 2:
Table S1) shows the characteristics of included studies and
(Additional file 3: Table S2) shows the characteristics of
excluded studies.
Within our sample, the mean standardised effect
size was 0.374, the mean total sample size was 149.3
(SD=217.4), ranging from 12 to 1,261, and themean IF was
3.14 (4.33), ranging from less than 1 to 33.79.Wewere able
to abstract the SE of the between-group difference directly
in two trials (2%), we calculated the SE from the 95% CI
of the between-group difference (Eq. 1) in 27 trials (27%),
and we calculated a the SE using Eq. 2 for the remaining
70 trials (71%). Authors explicitly identified their primary
outcome in 53 (54%) trials. Table 1 shows that no com-
ment on funding was made in 35 (35%) trials, whereas
authors specifically reported that there was no funding in
11 (11%) trials, and acknowledged a funder in 53 (54%)
trials. No comments were made about COIs in the reports
of 70 trials (71%), authors explicitly stated there were no
COIs in 22 trials (22%), and reported at least one COI in 7
trials (7%). We imputed zeros for IFs for 16 cases in which
13 unique journals did not have an official ISI IF. Table 1
also shows mean sample size, effect size, absolute effect
size, and IF by each of the funding and COI categories.
Fig. 1 Flow chart of excluded and included trials. The figure shows the path and number of excluded and included trials
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Table 1 Mean sample size, effect size (ES), absolute effect size, and IF, by categories of funding and reported COIs
N (%) Sample size (SD) ES (mean) abES (mean) IF (mean)
COI
None reported 70 (71) 149.9 (247.0) 0.389 0.67 3.144
Reported none 22 (22) 126.5 (177.1) 0.291 0.78 3.458
Reported some 7 (7) 214.6 (125.1) 0.409 0.41 6.001
Funding
None reported 35 (35) 61.8 (31.5) 0.324 0.53 2.004
Reported none 11 (11) 87.8 (42.4) 0.499 1.43∗∗∗ 2.155
Reported some 53 (54) 219.9 (277.6)∗∗∗ 0.371 0.62 4.102∗
∗P<0.05 (compared to none reported)
∗∗∗P=0.001 (compared to none reported)
Compared to not reporting any funding details, sample
size in trials reporting some funding was larger; absolute
effect size in trials reporting no funding was larger; and IF
in trials reporting some funding was higher.
Adjusted for trial sample size, there was no evidence of
a difference in journal IF between positive or negative tri-
als (P = 0.270). Adjusted for direction of effect, there was
very strong evidence of a linear association between IF
and sample size, suggesting that the IF of the publishing
journal increases by 0.008 (95% CI 0.004 to 0.012) per unit
increase in total sample size (P < 0.0005).
There was no evidence of an association (either linear
or non-linear) between effect size and IF (P = 0.527) but
journals with low IFs tended to report trials with a wider
range of effect sizes than high If journals (Fig. 2). Com-
pared to nothing being reported about COIs, there was no
evidence of an effect of reporting no COIs (P = 0.624)
or some COIs (P = 0.950). Compared to nothing being
reported about funding, there was no evidence of an effect
of reporting no funding (P = 0.481) or some funding
(P = 0.847). Table 2 shows full results, including both
crude and adjusted beta estimates, and covariates.
Table 3 shows the results of the meta-regression of
absolute magnitudes of effect size on COI categories and
funding categories, including covariates. There was no
evidence of an effect of IF on absolute effect size (P =
0.806). Compared to nothing being reported about COIs,
there was no evidence of an effect of reporting no COIs
(P = 0.512) or some COIs (P = 0.464). There was very
strong evidence of a large effect of reporting no fund-
ing compared to reporting no details about funding (β =
1.02,P = 0.001), and no evidence of an effect of report-
ing some funding compared to reporting no details about
funding (P = 0.506).
Fig. 2 Effect size by 2011 5-year journal impact factor. The figure shows the effect size and the variance of effect size by journal impact factor
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Table 2 Meta-regression: the effect of impact factor, COI, Funding category, year, and sample size on effect size
Unadjusted Adjustedb
β P 95% CI for β β P 95% CI for β
Impact factor
0.01 0.81 −0.04 to 0.05 0.02 0.53 −0.03 to 0.06
COI Categorya
Reported none −0.08 0.73 −0.55 to 0.39 −0.14 0.62 −0.68 to 0.41
Reported some 0.03 0.94 −0.70 to 0.76 0.02 0.95 −0.75 to 0.80
Funding Categorya
Reported none 0.19 0.59 −0.49 to 0.86 0.27 0.48 −0.48 to 1.02
Reported some 0.03 0.89 −0.39 to 0.45 0.05 0.85 −0.43 to 0.52
Publication year
−0.05 0.42 −0.16 to 0.07 −0.05 0.44 −0.17 to 0.08
Sample size
−0.0003 0.45 −0.001 to 0.0005 −0.0005 0.31 −0.002 to 0.0005
acomparison: none reported
bfor other variables in the model
As anticipated, residual variance due to heterogeneity
was high (91.06%> I2 > 85.76%) across all models.
Quadratic terms in IF and sample size were not signif-
icant in either unadjusted or adjusted models. Graphi-
cal inspection of standardised predicted random effects
showed adequate model fits. Sensitivity analyses (not
reported) showed near identical results.
Discussion
Main findings, implications and comparisons to existing
research
While no associations were found between effect size and
IF, reporting sources of funding, or conflicts of interest,
there was strong evidence of a large association between
absolute magnitude of effect size and the explicit report-
ing of ‘no funding’. We first discuss IF and then COIs and
funding.
Impact factor
The results show no evidence that IF is associated with
effect size reported in LBP trials. Effect size is much more
variable in journals with low IFs and since journals with
higher IFs tend to publish larger trials this likely explains
the relationship between effect size variance and journal
IF. Journal IF was not associated with direction of result,
although there was some evidence that trials reporting
a funder had a higher IF than those who did not report
funding status.
Table 3 Meta-regression: the effect of impact factor, COI, Funding category, year, and sample size and on absolute values of effect size
Unadjusted Adjustedb
β P 95% CI for β β P 95% CI for β
Impact factor
−0.01 0.54 −0.04 to 0.02 0.004 0.81 −0.03 to 0.04
COI Categorya
Reported none 0.13 0.52 −0.25 to 0.51 -0.14 0.51 −0.55 to 0.28
Reported some −0.24 0.42 −0.82 to 0.34 -0.21 0.46 −0.78 to 0.36
Funding Categorya
Reported none 0.94 0.001 0.42 to 1.45 1.02 0.001 0.44 to 1.59
Reported some 0.05 0.76 −0.27 to 0.37 0.12 0.51 −0.24 to 0.48
Publication year
−0.05 0.31 −0.14 to 0.05 −0.05 0.31 −0.14 to 0.05
Sample size
−0.0004 0.20 −0.001 to 0.0002 −0.0004 0.20 −0.001 to 0.0003
acomparison: none reported
bfor other variables in the model
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Suñé et al reviewed clinical trials evaluating drug ther-
apy published between 1997 and 2004 and classified the
outcomes of these trials as positive, negative, or descrip-
tive (non-controlled) [338]. They found no difference in
IF based on trial direction, but they found the IF was
significantly lower in trials classified as descriptive. Lit-
tner et al found that over a five-year period in the
field of neonatology, articles with negative results were
more likely than articles with positive results to be pub-
lished in journals with lower IFs [339]. Penel and Adenis
found the same pattern of association in phase II tri-
als investigating anticancer therapies [340]. Outside of
the medical fields, Murtaugh has explored the relation-
ship between standardised effects and IFs in published
meta-analyses of terrestrial plant competition, predation
in streams, woody plant growth under elevated CO2,
and marine nutrient enrichment experiments. Using raw
data, he similarly applied weighted least squares regres-
sion analysis of study-specific means of the absolute val-
ues of the log response ratios on log of journal IFs and
found some evidence that in two of the four areas stud-
ied (Nutrient enrichment experiments and predation in
streams) that journal IF was associated with reported
effects [341].
The presence or absence of associations differs across
different research areas. It may be that there is less compe-
tition in high-impact journals in terms of newsworthiness
of LBP trial results relative to other fields. As it is rare for
individual treatments for LBP to stand out dramatically
from others in terms of effect size, effect sizes in LBP tri-
als may not be a big driver of an acceptance decision in
higher-impact journals.
COI and funding status
We found no evidence that COI category or reported
funding status is associated with effect size reported in
LBP trials. However, we observed that absolute magni-
tudes of effect sizes tended to be about one SD larger
for trials that declared no funding compared with trials
that did not report funding status. The observed asso-
ciation is not due to confounding by sample size. Jacob
Cohen, who originally defined standardised effect sizes,
considered effect sizes of 0.2 or less to be small, 0.5 to
be medium, and 0.8 and above to be large [20]. Using
Cohen’s categorisation, the effect size in the larger trials of
interventions for LBP tend to be only small-to-medium in
magnitude [7].
This relationship is in marked contrast to that observed
in other fields, where evidence suggests industry-funded,
industry-linked studies, or studies with an industry-
funded author, report greater effect sizes than inde-
pendently funded studies [11, 12, 342, 343]. In the
authors’ experiences, LBP research trials tend to be
more commonly funded by government and charitable
organisations rather than by industry. It may be that, in
the case of LBP trials, reporting larger effect sizes, may be
higher amongst studies with fewer resources.
Our a priori approach was to compare categories
of explicitly reporting no funding/COIs, and explic-
itly reporting funding/COIs with not reporting anything
about funding/COIs, and it is these results that are
reported. As a post hoc comparison to explore reporting
of funding further, we compared trials that explicitly
reported having funding with trials that explicitly
reported not having funding, and found strong evidence
of a large effect (β = −0.89 (95% CI −1.46 to −0.33),
P = 0.002), suggesting that those reporting receiving fund-
ing, report considerably smaller effect sizes than those
reporting their trials were not funded.
Trial quality may partially explain the results. It has
been previously shown that larger trials in non-specific
LBP tend to be higher quality [17, 344]. We did not
explore trial quality in our study. Another consideration
may be that pragmatic trials tend to be done more often in
LBP research, since many interventions under assessment
are complex in nature and pharmacological interven-
tions (which are usually of efficacy rather than effective-
ness) [345] are comparatively rare. It may be that trials
more toward the pragmatic end of the spectrum, which
may be more difficult to do in the absence of funding
given their typical requirement to be large in scale, may
be associated with smaller effect sizes simply because
the comparator is often another active intervention. Con-
versely, efficacy trials may have higher effect sizes in
part due to more commonly utilising placebo/sham com-
parisons. We did not explicitly set out to explore this.
However, as another post hoc comparison we looked at the
intervention comparisons in our included trials, and those
that were compared to sham/placebo had an effect size
of 0.74 (large), in contrast with those compared to a non-
sham/placebo interventions, which had an effect size of
0.29 (P = 0.077; i.e weak evidence of a small-to-moderate
difference).
Strengths and limitations
Meta-regression modelling is most useful in this case as a
tool to assess the role of chance in the observed results.
We caution against use for prediction, since epistemolog-
ically this may not be entirely sensible: prediction may
involve a reversal of the direction of causality; authors
likely choose journals on the basis of publishing work they
believe to be newsworthy, high-quality, or of interest to a
particular journal’s readership. More robust and simpler
solutions to establishing the role of chance, and whether
relationships between effect size and IF are monotonic
could be used (such as non-parametric correlation) but,
as Murtaugh points out, such approaches are less able
to incorporate study-specific weights and are ultimately
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less powerful [341]. Also, such approaches are not as con-
ducive to the inclusion of covariates. In this study we had
sufficient power to detect a medium-to-large effect size in
terms of funding category, but not in terms of COI, which
were only reported in 7% of trials.
COIs disclosure may or may not be insisted upon by
a journal, or COI forms may have been completed but
not reported with the article. Additionally, disclosed COIs
may or may not be relevant to the trial. We explored
only the presence or absence of such statements reported
with the article and did not judge the relevance of dis-
closed COIs to the trial, nor whether the publishing jour-
nal required disclosure, and this as a limitation of our
study.
The large I2 values for the models suggests that the
residual variance explained by heterogeneity is very high.
This is to be expected since the included trials featured
many different interventions. In our analysis, other than
having a detrimental effect on power, the high I2 is incon-
sequential to interpretation and does not present a limita-
tion as it would in a meta-analysis of a specific treatment
effect. We were not focused on estimating the effect of a
specific intervention, but the association between effect
size and IF, COIs, and funding across many different inter-
ventions for nsLBP, some of which will naturally have
larger effects than others.
We imputed zero values for IF in the case of jour-
nals without an official IF. Many journals use unofficial
IFs and including these could have been used to intro-
duce more information into our models. We reasoned
that the majority of journals without official IFs would
likely have unofficial IFs of less than 1.00 and preferred
to use only official values. We note that if IFs had been
associated with effect size then our estimates may have
been exaggerated. As we did not find any association
with effect size, imputing values where there was no offi-
cial IF was of limited consequence and does not affect
conclusions.
In attempting to explain our results, we have hypoth-
esised that there may be a link to study quality, which
we did not explore. While there is some evidence of a
small effect of poor quality on effect size in LBP trials
from other work, we would welcome future investiga-
tions using the Cochrane Risk of Bias tool, since the
judgement criteria in this tool can be applied to either
pragmatic or efficacy trials without prejudice. Lower qual-
ity trials may have been associated with both absence of
definition of primary outcome measure, where we would
have used outcome measure selection method 3 or 4 (see
Methods section), as well as with larger study effects.
While we recorded and reported authors explicitly iden-
tifying an outcome as primary, for the trials in which this
was not explicitly identified, we did not record how often
primary outcome identification method 2, 3, or 4 needed
to be used. So we caution that there may have been an
unmeasured confounding factor.
We rejected trials from which we could not abstract
population-specific SD data required for the meta-
analysis. This resulted in 47 rejections and opens a possi-
bility for bias, in the case that not reporting these data is
also associated with reported effect size. While not specif-
ically an item in the CONSORT statement, this is some-
thing one might reasonably expect to be discussed within
a sample size calculation. For this reason, we suggest the
absence of its reporting, is more likely to be associated
with lower quality. Assuming this, and the premise that
lower quality trials report larger effect sizes notwithstand-
ing direction, are both correct, then our results will tend
toward being conservative.
Finally, we restricted our systematic review to three
large databases, reasoning that these index the majority of
nsLBP RCTs.We acknowledge however, that the review of
the period is unlikely to be exhaustive and that there may
be further associations between trials indexed in other
databases alone, and quality; and thus with the potential to
alter results. However, our results cover most of the field
and therefore provide a useful account of behaviour.
Recommendations
Based on our results we recommend that journal edi-
tors consider giving increased scrutiny at peer-review
stage to unfunded LBP trials. Researchers need to care-
fully consider whether the trial in question can be
adequately and appropriately conducted in the absence
of funding, and whether the protocol should be sub-
ject to peer review. Consumers of LBP trial reports
should note this relationship in the case trials are
unfunded.
The causal pathway for the relationship between fund-
ing and effect size needs further exploration. If larger
effect sizes yielded by unfunded trials are incorrect, these
may add noise to data consumed by review work decreas-
ing the precision of meta-analyses. If internal validity is
a factor, one might raise the question of whether it is
ethically justified to undertake unfunded trials of inter-
ventions for LBP. If the extent of the pragmatism of a
trial is a driving factor, then absorption of the higher
absolute effect sizes into specific review work is less of a
concern, but a scale of pragmatism might aid interpreta-
tion of effect size from individual trials and be useful to
reviewers.
Research into the relationship between funding status
and effect size, and IF and effect size, appears to be
dependent of the field of research and the nature of inter-
ventions under investigation. For this reason we suggest
that investigations are conducted across different fields
and interventions so that the relationships between COIs
and funding and effect size can be better understood
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and consumers can take this into consideration, as
appropriate.
Authors of LBP trials should explicitly report whether or
not funding was attained, as only around two-thirds of all
authors are currently doing this. Moreover, more authors
need to be explicit about whether or not there were COIs
as in our dataset only 29% of authors are doing this. Jour-
nals and editors could consider taking steps to ensuring
this information is reported.
Conclusions
While there is no evidence that reported funding status
and reported conflicts of interest influence effect size,
there is very strong evidence that authors who explic-
itly report that their LBP trial was unfunded tend to
report larger absolute magnitudes of effect size. Journal
editors, researchers, and consumers may have need to
be cautious of large effect sizes in unfunded trials, pos-
sibly giving additional scrutiny to internal validity. Our
results contrast with findings in pharmacological research
and suggests relationships may vary by field. Further
discipline-specific investigations would inform interpre-
tation of trial reports and help identify causal path-
ways of associations between effect sizes and trial/report
characteristics.
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